Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study
2012
Background
The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
43
References
14
Citations
NaN
KQI